Page 103 - Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022
P. 103

Malaysian Journal of Health Promotion, Vol 4 (Supplementary 1) 2022
                                                                    rd
                      14  MOH-AMM Scientific Meeting 2022 in conjunction with 23  NIH Scientific Conference Abstract Book
                        th
               The estimated cost per ambulance utilization per month was calculated using apportionment
               methods.  One-way  sensitivity  analysis  with  a  20%  change  in  the  magnitude  of  the  input
               variables was performed to identify key drivers of the ambulance services cost.
               RESULTS:  The  analysis  estimated  that  the  total  cost  per  month  of  ambulance  services  in
               hospitals and clinics were MYR 11,410.44 and MYR 9,574.39, respectively. The unit cost per
               ambulance utilization for hospitals was calculated at MYR 330.15 per trip, MYR 5.50 per km
               travelled, and MYR 184.09 per hour. Whereas the unit cost of ambulance services for clinics
               was MYR 225.68 per trip MYR 4.25 per km travelled, and MYR 105.13 per hour. A sensitivity
               analysis revealed that personnel salary and duration of ambulance usage were the key drivers
               of the ambulance costs.
               DISCUSSION/CONCLUSION: Estimates provided in this study may be useful for policymakers
               as a benchmark cost for the possibility of future policy for outsourcing the ambulance services.

               ID 111 THE EFFECTS OF CANCER-RELATED COSTS ON LOWER-INCOME GROUP OF PATIENTS:
               AFFORDABILITY APPROACH

               Nur Amalina Zaimi, Farhana Aminuddin, Nor Zam Azihan Mohd Hassan
               Centre of Health Economics Research, Institute for Health Systems Research, National Institutes of Health (NIH),
               Ministry of Health Malaysia

               INTRODUCTION: Cancer has a significant economic impact on both patients and the country’s
               health system. For cancer patients, cancer may impose significant economic costs. This study
               aimed to assess the affordability of healthcare among the lower-income group of cancer
               patients through impoverishment and catastrophic approach.
               METHODS:  A  cross-sectional  design  study  was  conducted from the perspective  of  cancer
               patients from the lower-income group in Malaysia (Bottom 40 per cent, B40). An interviewer-
               administered questionnaire was performed using a structured questionnaire which covers a
               section on sociodemographic, costs related to cancer and household expenditure. A poverty
               line income in Malaysia (RM2,208) was used to determine impoverishment and thresholds at
               10, 25 and 40 per cent were used to calculate the catastrophic expenditure of cancer-related
               costs.
               RESULTS: This study found that before spending on cancer-related costs, 56.4 per cent (n=22)
               households were already lived below the poverty line. After spending, 66.7 per cent (n=26)
               households became impoverished below the poverty line. Findings of this study also showed
               that 24 households experienced catastrophic expenditure, followed by 10 and 14 households
               at 10, 25 and 40 per cent thresholds respectively.
               DISCUSSION/CONCLUSION: The out-of-pocket payments for cancer-related costs impose a
               significant  risk  on  the  lower-income  household  for  experiencing  impoverishment  and
               catastrophic spending. These further warrants attention by the government to focus on the
               need of cancer patients, especially those affected financially.

               ID  112  COST  ANALYSIS  OF  PHARMACY  VALUE-ADDED  SERVICES  IN  PUBLIC  HEALTH
               FACILITIES

               Izzati Yussof, Nor Haizan Ibrahim @ Ghazali, Asilah Che Ayub, Norsyazana Ab Hashim, Choon Ching Ju, Chee
               Chew Yee, Asma Amalina Abdul Rani and Helmi Hafiz Hashim
               Pharmaceutical Services Division, Kuala Lumpur & Putrajaya Health Department, Ministry of Health Malaysia,
               Kuala Lumpur




                                                                                                       77
   98   99   100   101   102   103   104   105   106   107   108